App Logo
DEEN
Start for free
BRUI

Private Equity, VC & Investor

Breega vs UI Investissement

Structured technology and market comparison · 2026

Direct Feature Comparison

Breega · vs · UI Investissement
Market Cluster / Sector
BreegaPrivate Equity, VC & Investor
UI InvestissementPrivate Equity, VC & Investor
Platform Focus
Breega

European and African early-stage venture capital fund manager.

UI Investissement

French private equity investor focused on SMEs and mid-caps.

Company Size
Breega10–49 employees
UI Investissement50–200 employees
Headquarters
BreegaFR
UI InvestissementFR
Year Founded
Breega2013
UI InvestissementUnknown
Dossier & Alternatives

Analyze all overlapping signals and tech stacks for Breega and UI Investissement

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare free in ExplorerFree · No credit card · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between Breega and UI Investissement?

When comparing Breega and UI Investissement, both platforms operate within the Private Equity, VC & Investor ecosystem. Breega is positioned as European and African early-stage venture capital fund manager, whereas UI Investissement focuses on French private equity investor focused on SMEs and mid-caps. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to Breega and UI Investissement?

When evaluating Breega and UI Investissement, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of Breega and UI Investissement compare?

Breega is headquartered in FR (founded in 2013) with 10–49 employees. UI Investissement is based in FR (founding year unrecorded) with 50–200 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: Breega vs UI Investissement

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

BR

Breega

Recent Signals

  • ·EU-Startups (European Venture)Funding

    Cori Clinical Raises €3.8M to Accelerate Clinical Trials

    London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.

    • Cori Clinical raised €3.8 million in a Seed round led by Breega.
    • Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
    • Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
View all signals for Breega →
UI

UI Investissement

Recent Signals

View all signals for UI Investissement →

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Breega and UI Investissement share across the market ecosystem.

Start for freeBreega ProfileUI Investissement Profile